During the past decade, University of Louisville Hospital conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 24 clinical trials were completed, i.e. on average, 63.2% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 7 clinical trials were completed. i.e. 26.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Louisville Hospital" #1 sponsor was "University of Louisville" with 26 trials, followed by "Bristol-Myers Squibb" with 4 trials sponsored, "Pfizer" with 4 trials sponsored, "Mesoblast, Inc." with 2 trials sponsored and "Regeneron Pharmaceuticals" with 2 trials sponsored. Other sponsors include 41 different institutions and companies that sponsored additional 51 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Louisville Hospital" #1 collaborator was "Bristol-Myers Squibb" with 4 trials as a collaborator, "Medical University of South Carolina" with 4 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 4 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator and "National Institute of Nursing Research (NINR)" with 2 trials as a collaborator. Other collaborators include 33 different institutions and companies that were collaborators in the rest 38 trials.

According to Clinical.Site data, the most researched conditions in "University of Louisville Hospital" are "Melanoma" (5 trials), "Stroke" (4 trials), "Crohn's Disease" (3 trials), "Ischemic Stroke" (3 trials) and "Metastatic Melanoma" (3 trials). Many other conditions were trialed in "University of Louisville Hospital" in a lesser frequency.

Most popular intervention types in "University of Louisville Hospital" are "Drug" (48 trials), "Device" (15 trials), "Biological" (11 trials), "Procedure" (6 trials) and "Other" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Apixaban" (4 trials), "Nivolumab" (4 trials), "placebo" (4 trials) and "Aspirin" (3 trials). Other intervention names were less common.

The vast majority of trials in "University of Louisville Hospital" are 77 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Louisville Hospital". undefined are not yet recruiting, 15 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 41 completed trials in University of Louisville Hospital, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in University of Louisville Hospital, 5 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 16 trials that are defined as “Not Applicable".